199 related articles for article (PubMed ID: 31646996)
21. Effects of tadalafil on storage and voiding function in patients with male lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A urodynamic-based study.
Matsukawa Y; Majima T; Matsuo K; Funahashi Y; Kato M; Yamamoto T; Gotoh M
Int J Urol; 2018 Mar; 25(3):246-250. PubMed ID: 29164680
[TBL] [Abstract][Full Text] [Related]
22. Early improvement of storage or voiding symptoms by tadalafil predicts treatment outcomes in patients with lower urinary tract symptoms from benign prostatic hyperplasia.
Yokoyama O; Ozeki A; Suzuki N; Murakami M
Int J Urol; 2018 Mar; 25(3):240-245. PubMed ID: 29094398
[TBL] [Abstract][Full Text] [Related]
23. Effects of tadalafil on lower urinary tract symptoms secondary to benign prostatic hyperplasia and on erectile dysfunction in sexually active men with both conditions: analyses of pooled data from four randomized, placebo-controlled tadalafil clinical studies.
Porst H; Roehrborn CG; Secrest RJ; Esler A; Viktrup L
J Sex Med; 2013 Aug; 10(8):2044-52. PubMed ID: 23782459
[TBL] [Abstract][Full Text] [Related]
24. Tadalafil for the treatment of benign prostatic hyperplasia.
Mónica FZ; De Nucci G
Expert Opin Pharmacother; 2019 Jun; 20(8):929-937. PubMed ID: 30901259
[TBL] [Abstract][Full Text] [Related]
25. Mechanism of action of phosphodiesterase type 5 inhibition in metabolic syndrome-associated prostate alterations: an experimental study in the rabbit.
Morelli A; Comeglio P; Filippi S; Sarchielli E; Vignozzi L; Maneschi E; Cellai I; Gacci M; Lenzi A; Vannelli GB; Maggi M
Prostate; 2013 Mar; 73(4):428-41. PubMed ID: 22996758
[TBL] [Abstract][Full Text] [Related]
26. [Experimental rodent models of chronic prostatitis: effect of phosphodiesterase 5 inhibitor on chronic pelvic-pain-related behavior].
Yamaguchi H; Kurita M; Yoshinaga R; Asao Y; Oka M
Nihon Yakurigaku Zasshi; 2019; 154(5):259-264. PubMed ID: 31735755
[TBL] [Abstract][Full Text] [Related]
27. Safety and efficacy of the combination of once-daily tadalafil and alpha-1 blocker in Japanese men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A randomized, placebo-controlled, cross-over study.
Takeda M; Yokoyama O; Yoshida M; Nishizawa O; Hirata K; Nakaoka R; Takita Y; Murakami M
Int J Urol; 2017 Jul; 24(7):539-547. PubMed ID: 28556284
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and Safety of a Fixed-Dose Combination Therapy of Tamsulosin and Tadalafil for Patients With Lower Urinary Tract Symptoms and Erectile Dysfunction: Results of a Randomized, Double-Blinded, Active-Controlled Trial.
Kim SW; Park NC; Lee SW; Yang DY; Park JK; Moon DG; Yang SK; Lee SW; Moon KH; Ahn TY; Kim SW; Park K; Min KS; Ryu JK; Son H; Jung J; Hyun JS
J Sex Med; 2017 Aug; 14(8):1018-1027. PubMed ID: 28760246
[TBL] [Abstract][Full Text] [Related]
29. Changes in the oxidative stress factors and inflammatory proteins following the treatment of BPH-induced dogs with an anti-proliferative agent called tadalafil.
Dearakhshandeh N; Mogheiseh A; Nazifi S; Ahrari Khafi MS; Abbaszadeh Hasiri M; Golchin-Rad K
J Vet Pharmacol Ther; 2019 Nov; 42(6):665-672. PubMed ID: 31410874
[TBL] [Abstract][Full Text] [Related]
30. [Effect of Qianlean Pill on IL-1β, IL-10, and TNF-α in Prostate Tissues of Chronic Nonbacterial Prostatitis Rats].
Zou RZ; Cao JG; Feng QZ; Sun JQ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Oct; 35(10):1223-7. PubMed ID: 26677675
[TBL] [Abstract][Full Text] [Related]
31. Phosphodiesterase type 5 expression in human and rat lower urinary tract tissues and the effect of tadalafil on prostate gland oxygenation in spontaneously hypertensive rats.
Morelli A; Sarchielli E; Comeglio P; Filippi S; Mancina R; Gacci M; Vignozzi L; Carini M; Vannelli GB; Maggi M
J Sex Med; 2011 Oct; 8(10):2746-60. PubMed ID: 21812935
[TBL] [Abstract][Full Text] [Related]
32. Silodosin and tadalafil have synergistic inhibitory effects on nerve-mediated contractions of human and rat isolated prostates.
Buono R; Briganti A; Freschi M; Villa L; La Croce G; Moschini M; Benigni F; Castiglione F; Montorsi F; Hedlund P
Eur J Pharmacol; 2014 Dec; 744():42-51. PubMed ID: 25261033
[TBL] [Abstract][Full Text] [Related]
33. [Tadalafil Ameliorates Symptoms of Patients with Benign Prostatic Hyperplasia Complicated by Chronic Pelvic Pain Syndrome].
Nishino Y; Miwa K; Moriyama Y; Fujihiro S; Masue T; Kikuchi M; Nakai C; Deguchi T
Hinyokika Kiyo; 2017 Mar; 63(3):101-105. PubMed ID: 28331166
[TBL] [Abstract][Full Text] [Related]
34. Administration of daily 5 mg tadalafil improves endothelial function in patients with benign prostatic hyperplasia.
Amano T; Earle C; Imao T; Matsumoto Y; Kishikage T
Aging Male; 2018 Mar; 21(1):77-82. PubMed ID: 28830281
[TBL] [Abstract][Full Text] [Related]
35. Matrix metalloproteinases in the pathogenesis of estradiol-induced nonbacterial prostatitis in the lateral prostate lobe of the Wistar rat.
Wilson MJ; Woodson M; Wiehr C; Reddy A; Sinha AA
Exp Mol Pathol; 2004 Aug; 77(1):7-17. PubMed ID: 15215045
[TBL] [Abstract][Full Text] [Related]
36. Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.
Fusco F; D'Anzeo G; Henneges C; Rossi A; Büttner H; Nickel JC
PLoS One; 2015; 10(8):e0135484. PubMed ID: 26284523
[TBL] [Abstract][Full Text] [Related]
37. Tadalafil, a phosphodiesterase type 5 inhibitor, improves bladder blood supply and restores the initial phase of lower urinary tract dysfunction in diabetic rats.
Gotoh D; Torimoto K; Tatsumi Y; Hori S; Yamada A; Miyake M; Morizawa Y; Aoki K; Tanaka N; Hirayama A; Fujimoto K
Neurourol Urodyn; 2018 Feb; 37(2):666-672. PubMed ID: 28782191
[TBL] [Abstract][Full Text] [Related]
38. Nonbacterial prostatitis caused by partial urethral obstruction in the rat.
Takechi S; Yokoyama M; Tanji N; Nishio S; Araki N
Urol Res; 1999 Oct; 27(5):346-50. PubMed ID: 10550522
[TBL] [Abstract][Full Text] [Related]
39. A comparative randomized prospective study to evaluate efficacy and safety of combination of tamsulosin and tadalafil vs. tamsulosin or tadalafil alone in patients with lower urinary tract symptoms due to benign prostatic hyperplasia.
Singh DV; Mete UK; Mandal AK; Singh SK
J Sex Med; 2014 Jan; 11(1):187-96. PubMed ID: 24165272
[TBL] [Abstract][Full Text] [Related]
40. Phosphodiesterase 5 inhibitor suppresses prostate weight increase in type 2 diabetic rats.
Kobayashi H; Zha X; Nagase K; Inamura S; Taga M; Aoki Y; Ito H; Yokoyama O
Life Sci; 2022 Jun; 298():120504. PubMed ID: 35367242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
